EPO Patents = 15

Trademarks = 1

Forward Citations = 2

Loading Chart...

30 inventors (with patents filed for the assignee):

Wenyuan Qian (2 out of 23 patents)

Shuhui Chen (1 out of 234 patents)

Dahai Wang (1 out of 13 patents)

4. Shilan Liu (1 out of 13 patents)

5. Hui Liu (1 out of 51 patents)

6. Peng Yu (1 out of 4 patents)

7. Jinfeng Li (1 out of 8 patents)

8. Changqing Wei (1 out of 12 patents)

9. Jia Liu (1 out of 80 patents)

10. Xiaoyang Shen (1 out of 6 patents)

11. Jianhua Shang (1 out of 2 patents)

12. Yunqi Gong (1 out of 1 patent)

13. Jinxin Chen (1 out of 1 patent)

14. Fang Fang (1 out of 1 patent)

15. Qingbin Meng (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12391653 - Salt form and crystal form of mutant IDH1 inhibitor and preparation method therefor (2025-08-19),

2. 11744841 - Use of trezastilbenoside in manufacture of product for treating and/or preventing disease of respiratory system (2023-09-05),

3. 11407717 - Benzimidazole derivatives and use thereof as IDH1 inhibitors (2022-08-09),

4. 10307453 - Method for extracting stilbene compounds (2019-06-04),

5. 9623111 - Pegylated artesunate derivative, pharmaceutical composition and use thereof (2017-04-18),

Kpc Pharmaceuticals is a leading pharmaceutical company focused on research, development, and manufacturing of high-quality and cost-effective generic medicines. With a strong commitment to innovation and customer satisfaction, Kpc Pharmaceuticals aims to improve global access to affordable healthcare solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

5 Patents

#5 in Yunnan

#5,211 in China

Yunnan, China

Kpc Pharmaceuticals, Inc.